Login
$RARE
$15.85 -$0.05 (0.31%) After hours

Ownership

13F as of Q2 2026 · 102.1M shares outstanding

Who owns RARE?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 61.4%
Kakkis Emil D 11.7% · BlackRock, Inc. 10.4%
Institutional ownership
100.0%
+3.9 pts vs last qtr
Institutional holders
310
+11 vs last qtr
Net shares bought
+8.4M
by institutions in Q2 2026
New / sold out
59 / 48
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • RTW Investments, LP +4.1M
  • BlackRock, Inc. +3.4M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Assenagon Asset Management S.A. −2.1M
  • Citadel Advisors LLC −1.9M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$1.47M
16 notices from 5 people
Shares covered
59.8K
0.06% of the company
Arranged in advance
82%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$157.6K$315.2KDec 2025: $112.1K under a 10b5-1 planDecJan 2026: $71.9K under a 10b5-1 planJanFeb 2026: $72.1K under a 10b5-1 planFebMar 2026: $106.9K under a 10b5-1 planMar 2026: $208.3K without a planMarApr 2026: $98.2K under a 10b5-1 planAprMay 2026: $260.8K under a 10b5-1 planMayJun 2026: $203.1K under a 10b5-1 planJun 2026: $50.1K without a planJunJul 2026: $155.6K under a 10b5-1 planJulAug 2026: $117.0K under a 10b5-1 planAugSep 2026: $17.5K under a 10b5-1 planSepOctNov
Largest proposed sellers
  • Howard Horn Officer 10b5-1 $961K
  • Karah Parschauer Officer $301K

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2014–FY2025
+242.9%
+19.25% a year
Each share's claim on the business
−70.8%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $30.3M
over 8 fiscal years
Diluted shares, split-adjusted
27.9M63.7M99.6M2014: 28.8M shares'142015: 36.8M shares'152020: 60.8M shares'202021: 67.8M shares'212022: 69.9M shares'222023: 73.5M shares'232024: 90.5M shares'242025: 98.6M shares'25
Buybacks Stock-based comp
$0$12.4M$24.9M2014 buybacks: $02014 stock comp: $5.4M'142015 buybacks: $02015 stock comp: $24.9M'152020 buybacks: $02020 stock comp: $0'202021 buybacks: $02021 stock comp: $0'212022 buybacks: $02022 stock comp: $0'222023 buybacks: $02023 stock comp: $0'232024 buybacks: $02024 stock comp: $0'242025 buybacks: $02025 stock comp: $0'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years47% 3–5 years20% 1–3 years19% Under 1 year15%
Quarterly turnover
23.8%
of institutional shares changed hands
Top 10 managers, median time held
4.5 years

Super Investors

Investment managers reporting RARE on Form 13F
B
BlackRock, Inc.
Shares
10.7M
% of company
10.44%
Change vs last qtr
+3.4M (+46.0%)
Held since
≤2021
RI
RTW Investments, LP
Shares
7.8M
% of company
7.64%
Change vs last qtr
+4.1M (+113.7%)
Held since
2021

28 more super investors behind a free account

See every manager holding Ultragenyx Pharmaceutical Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting RARE on Form N-PORT; together they hold 33.8% of the company
Position value
$122M
% of company
3.59%
% of the fund
1.14%
As of
June 30, 2026
VT
Position value
$99.7M
% of company
2.93%
% of the fund
0.00%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Ultragenyx Pharmaceutical Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
KE
Kakkis Emil D
Insider
Shares
11.9M
% of company
11.65%
Change vs last qtr
—
Held since
—
KT
Kassberg Thomas Richard
Insider
Shares
264.7K
% of company
0.26%
Change vs last qtr
—
Held since
—

14 more holders behind a free account

See every insider and 5%+ holder of Ultragenyx Pharmaceutical Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support